EGFR Gene Mutation Testing by MassARRAY: Registration, Validation and Quality Standards

Overview

Procurement teams evaluating a MassARRAY-based EGFR service are rarely asking whether mass spectrometry works. The real question is documentary: which mutation list has been formally validated, under which accreditation scope the laboratory reports, and what evidence travels with each reagent lot. This article treats the assay as a regulated deliverable and maps the paperwork that should accompany it.

How It Works

The platform genotypes a fixed, pre-specified list of positions. Target regions are amplified, then a single-base extension reaction adds one nucleotide at each interrogated position, generating products whose molecular mass differs according to which base was incorporated. Mass spectrometry separates those products by mass-to-charge ratio, and allele calls follow directly from the measured peaks. Because detection rests on physical mass rather than fluorescent interpretation, calls are crisp, but the design is inherently closed: positions absent from the panel definition are simply not examined, whatever they might contain. That closed architecture is exactly what makes formal validation tractable and what makes panel scope a compliance question rather than a technical footnote.

Indications

The format fits laboratories requiring reproducible genotyping of an agreed EGFR hotspot set for therapy selection, where a defined and auditable mutation list is acceptable and broad discovery is not the goal. Where novel or unlisted variants must be captured, an open sequencing method is the appropriate instrument and the closed panel should not be presented as equivalent.

Specifications and Documentation

Request the validation report and read it for analytical sensitivity per position, specificity, repeatability across operators and runs, and the reference materials used. Confirm the laboratory holds accreditation such as ISO 15189, and verify that EGFR genotyping falls inside the listed scope rather than merely being performed on site. Ask for external quality assessment participation records and recent performance. Where reagents are supplied as a registered kit, obtain the registration number and confirm the approved intended use; where the test is laboratory-developed, expect a correspondingly fuller internal validation file.

Storage and Sourcing

Reagent kits arrive with defined temperature conditions and expiry dating, so require certificates of analysis, lot numbers and continuous temperature records for each shipment. Confirm remaining shelf life on arrival and whether the supplier will replace lots consumed by customs delay. For cross-border movement, check that documentation names the correct legal manufacturer and that labelling matches the registered particulars, since a mismatch between carton and registration is a routine cause of clearance holds.

FAQ

Q: What accreditation evidence should we request for a MassARRAY EGFR service? Ask for the accreditation certificate together with the annexed scope, and confirm this specific genotyping method appears within it. Accreditation held for unrelated disciplines does not cover the assay you are buying.

Q: How is a closed mutation panel validated differently from an open sequencing assay? A closed panel is validated position by position against known reference material, producing a finite performance table. Open sequencing is validated for variant classes and coverage, so its documentation describes capability across regions rather than per-position sensitivity.

Q: Which lot documentation matters when reagent kits cross a border? Certificates of analysis, lot numbers, expiry dating and temperature records during transit. Also confirm the registered manufacturer name on the carton matches the registration file, as discrepancies stall clearance more often than product defects.